Generic Rx Dispensing Fee Wins Approval

AUGUST 01, 2006

Community pharmacists in Louisiana will be encouraged to dispense generics for their Medicaid patients under new legislation approved by the state's lawmakers. The bill, which has drawn strong support from independent pharmacy leaders in Louisiana and elsewhere, seeks to address community pharmacy's concerns about the newly enacted Federal Deficit Reduction Act.

Starting next year, the "average manufacturer price" provisions in that law will trigger significant reductions in Medicaid reimbursement rates to pharmacists for generic prescriptions, representatives at the National Community Pharmacists Association (NCPA) said. The Louisiana legislation would authorize a Medicaid dispensing fee of up to $15 for generics?one third more than the fee for dispensing brand name drugs.

"We applaud the Louisiana legislature for taking this important step in working with pharmacists in their state to find the highest level of savings on prescription drugs," NCPA Executive Vice President and Chief Executive Officer Bruce Roberts, RPh, said.


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.